This inventor holds 4 USPTO granted patents and 5 published patent applications and 5 EPO patents. Top assignees: Lotte Fine Chemical Co., Ltd., Samsung Fine Chemicals Co., Ltd.. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014-2017
Title: Hyon Ho Baek: Innovator in Enteric Hard Capsule Technology
Introduction
Hyon Ho Baek is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of enteric hard capsules. With a total of 4 patents to his name, Baek's work focuses on enhancing the stability and effectiveness of oral drug delivery systems.
Latest Patents
Baek's latest patents include innovative compositions for enteric hard capsules. One of his key inventions is a composition that includes a polyol with at least three hydroxyl groups. This composition is designed to delay the separation of salt from the capsule during storage. Another significant patent involves a composition for forming a complex, which includes a cellulose-based compound and a polyphenol-based compound. This composite can be dissolved in various pH ranges, making it useful in medical and food applications where pH-dependent film characteristics are required.
Career Highlights
Throughout his career, Hyon Ho Baek has worked with prominent companies such as Samsung Fine Chemicals Co., Ltd. and Lotte Fine Chemical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in chemical formulations and patent development.
Collaborations
Baek has collaborated with notable colleagues in his field, including Sung Wan Lee and Jae Uk Cha. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Hyon Ho Baek is a distinguished inventor whose work in enteric hard capsule technology has the potential to significantly impact the pharmaceutical industry. His innovative approaches and collaborations highlight his commitment to advancing drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile